Primary practice
Find Dr. Liebross' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Liebross practices at Witham Health Services in Lebanon, Indiana, part of Parkview Health System.
Dr. Liebross' NPI, 1598850653, was assigned on October 4, 2006. Dr. Liebross graduated from New York University School of Medicine in 1995. Dr. Liebross holds Indiana license 01052367.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Liebross' primary practice is Witham Health Services, at 2605 N Lebanon St, Lebanon, IN 46052 in Boone County. The practice phone is (765) 485-8000.
Source: Dmand AI Affiliation Data
Dr. Liebross' primary practice is Witham Health Services in Lebanon, Indiana, part of Parkview Health System. Dr. Liebross is also affiliated with Ascension St. Vincent Hospital - Indianapolis. The medical group on file is Cancer Care Group. Dmand AI also links Dr. Liebross to 4 more hospitals and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liebross practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Witham Health Services | Available with a free account |
| +5 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Parkview Health System and 6.2K+ hospitals, with verified contacts in the same login.
Radiation oncology is Dr. Liebross' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Liebross is licensed in Indiana.
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 2,151 Medicare services from Dr. Liebross across 20 procedure codes in 2024, for 364 Medicare patients. Medicare paid $122,815 for them. Every service was in a facility, such as a hospital, rather than an office.
Medians across 120 radiation oncologists in Indiana with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Liebross?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Liebross and other radiation oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 364 Medicare patients who saw Dr. Liebross in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Liebross' median patient age at 72, with 53% women.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 72
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Liebross wrote 446 Medicare Part D claims for 176 patients. 99% of them were for generic drugs. CMS names the drug for 297 of them, across 14 drugs with 11 or more claims each, at $4,135 in total drug cost. In 2023, CMS named 161 claims across 8 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 14 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Liebross accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links Dr. Liebross to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.
Conditions in Dr. Liebross' trials
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 147 general payments to Dr. Liebross from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. INSYS Therapeutics Inc paid the most, $81,799.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Liebross graduated from New York University School of Medicine in 1995.
Source: Dmand AI Professional Profile Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Robert Howard Liebross' NPI number is 1598850653. It was assigned on October 4, 2006, and it is active in the NPI Registry.
Dr. Robert Howard Liebross is a radiation oncologist in Lebanon, Indiana. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Dr. Liebross practices at 2605 N Lebanon St, Lebanon, IN 46052. Dr. Liebross' primary practice is Witham Health Services in Lebanon, Indiana, part of Parkview Health System. Dmand AI also links Dr. Liebross to 4 hospitals and 2 medical groups.
The practice phone on file for Dr. Liebross is (765) 485-8000.
Dr. Liebross holds Indiana license 01052367.
Dr. Liebross practices at Witham Health Services in Lebanon, Indiana. Dr. Liebross is also affiliated with Ascension St. Vincent Hospital - Indianapolis. Dmand AI links Dr. Liebross to 4 more hospitals.
Dr. Liebross is linked to Cancer Care Group. Dmand AI links Dr. Liebross to 2 more medical groups.
Yes. CMS data shows Dr. Liebross billed Medicare for 2,151 services in 2024, and Dr. Liebross accepts Medicare assignment.
CMS counts 364 Medicare patients who saw Dr. Liebross in 2024, with an average age of 74.
In 2024, Dr. Liebross' most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and radiation oncology (77334).
Dr. Liebross graduated from New York University School of Medicine in 1995.
In 2024 Medicare Part D data, Dr. Liebross' most prescribed drugs by claims were Tamsulosin HCl, Hydrocodone-Acetaminophen and Mometasone Furoate.
CMS Open Payments shows $87,541 in general payments to Dr. Liebross from 24 companies from 2016 to 2025. The largest total came from INSYS Therapeutics Inc.
Dr. Liebross graduated from medical school in 1995, 31 years ago.
Dr. Liebross has worked on 1 clinical trial.
Selling to radiation oncology practices?
See radiation oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.